Clinical trial
Tumor Ablation With Talaporfin Sodium and Interstitial Light Emitting Diodes…
NCT00122876 · Light Sciences Oncology, Industry · Completed
Key facts
| NCT number | NCT00122876 |
|---|---|
| Title | Tumor Ablation With Talaporfin Sodium and Interstitial Light Emitting Diodes Treating Hepatocellular Carcinoma (HCC) |
| Official title | A Phase 1/2 Open-Label Study to Evaluate Safety and Preliminary Evidence of Effectiveness of Tumor Ablation With Talaporfin Sodium (LS11) and Interstitial Light Emitting Diodes (LEDs) in the Treatment of Subjects With Inoperable Hepatocellular Carcinoma (HCC) |
| Lead sponsor | Light Sciences Oncology, Industry |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Carcinoma, Hepatocellular, Liver Neoplasms |
| Intervention type | Drug, Procedure |
| Interventions | Photodynamic therapy, Talaporfin Sodium |
| Enrollment | 25 |
| Start date | Apr 1, 2005 |
| Completion | Oct 1, 2006 |
| First posted | Jul 22, 2005 |
| Last update posted | Dec 7, 2007 |
| Countries | Hong Kong, Singapore, Taiwan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: